Metsä Board Oyj (LON:0O7A)
London · Delayed Price · Currency is GBP · Price in EUR 2.932
+0.023 (0.77%)
At close: Dec 12, 2025
Metsä Board Oyj Revenue
Metsä Board Oyj had revenue of 441.20M EUR in the quarter ending September 30, 2025, a decrease of -11.58%. This brings the company's revenue in the last twelve months to 1.83B, down -4.56% year-over-year. In the year 2024, Metsä Board Oyj had annual revenue of 1.94B, down -0.19%.
Revenue (ttm)
1.83B EUR
Revenue Growth
-4.56%
P/S Ratio
0.60
Revenue / Employee
800.57K EUR
Employees
2,290
Market Cap
957.78M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.94B | -3.70M | -0.19% |
| Dec 31, 2023 | 1.95B | -538.30M | -21.66% |
| Dec 31, 2022 | 2.49B | 397.10M | 19.01% |
| Dec 31, 2021 | 2.09B | 195.70M | 10.34% |
| Dec 31, 2020 | 1.89B | -44.90M | -2.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |
Metsä Board Oyj News
- 7 weeks ago - Metsa Board Oyj (FRA:MSRB) Q3 2025 Earnings Call Highlights: Navigating Challenges with ... - GuruFocus
- 2 months ago - Metsä Board Discontinues Pre-engineering Investments; Could Cut Up To 315 Jobs - Nasdaq